Siglec‐15 promotes the migration of liver cancer cells by repressing lysosomal degradation of CD44
Sign Up to like & getrecommendations! Published in 2021 at "FEBS Letters"
DOI: 10.1002/1873-3468.14169
Abstract: Sialic acid‐binding immunoglobulin‐like lectin‐15 (Siglec‐15) has been identified as a novel potential target for cancer immunotherapy. Here, we explored the role of Siglec‐15 in human hepatoma cells. In this study, we found that the expression… read more here.
Keywords: siglec; hepatoma cells; promotes migration; cd44 ... See more keywords